Clinical Trial Update: Immune Checkpoint Inhibitors and Anti-vascular Endothelial Growth Factor Antibody/tyrosine Kinase Inhibitors with or Without HAIC for Advanced HCC

View source ↗

Summary

A ClinicalTrials.gov entry describes a study evaluating immune checkpoint inhibitors with or without anti-VEGF antibody/tyrosine kinase inhibitors therapy plus …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Hepatic arterial infusion chemotherapy (HAIC) (hepatic arterial infusion chemotherapy)
• Immune checkpoint inhibitors (immune checkpoint inhibitor)
• anti-VEGF antibody/tyrosine kinase inhibitors

Snippet

Sponsor: Zhongda Hospital | Conditions: Hepatocellular Carcinoma (HCC) | Status: RECRUITING